PH31682A - 4-Iminoquinolines, process for their preparation, and their use. - Google Patents

4-Iminoquinolines, process for their preparation, and their use.

Info

Publication number
PH31682A
PH31682A PH46420A PH46420A PH31682A PH 31682 A PH31682 A PH 31682A PH 46420 A PH46420 A PH 46420A PH 46420 A PH46420 A PH 46420A PH 31682 A PH31682 A PH 31682A
Authority
PH
Philippines
Prior art keywords
iminoquinolines
preparation
image
formula
substituents
Prior art date
Application number
PH46420A
Other languages
English (en)
Inventor
Billhardt-Troughton Uta-Maria
Rosner Manfred
Bender Rudolf
Meichner Christoph
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH31682A publication Critical patent/PH31682A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Detergent Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PH46420A 1992-06-27 1993-06-25 4-Iminoquinolines, process for their preparation, and their use. PH31682A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221210 1992-06-27

Publications (1)

Publication Number Publication Date
PH31682A true PH31682A (en) 1999-01-18

Family

ID=6462017

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46420A PH31682A (en) 1992-06-27 1993-06-25 4-Iminoquinolines, process for their preparation, and their use.

Country Status (19)

Country Link
US (1) US5602146A (hu)
EP (1) EP0579968B1 (hu)
JP (1) JP3605123B2 (hu)
KR (1) KR940005577A (hu)
CN (1) CN1083477A (hu)
AT (1) ATE184003T1 (hu)
AU (1) AU670435B2 (hu)
CA (1) CA2099213C (hu)
DE (1) DE59309756D1 (hu)
DK (1) DK0579968T3 (hu)
ES (1) ES2136628T3 (hu)
GR (1) GR3031853T3 (hu)
HU (1) HUT70040A (hu)
IL (1) IL106147A (hu)
MX (1) MX9303843A (hu)
NZ (1) NZ247993A (hu)
PH (1) PH31682A (hu)
TW (1) TW304945B (hu)
ZA (1) ZA934576B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4428932A1 (de) * 1994-08-16 1996-02-22 Hoechst Ag Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
AU2005249363A1 (en) * 2004-04-14 2005-12-15 Zhenhong R. Cai Phosphonate analogs of HIV integrase inhibitor compounds
US20110123929A1 (en) * 2007-01-23 2011-05-26 Fujifilm Corporation Oxime compound, photosensitive composition, color filter, production method for the color filter, and liquid crystal display element
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
JP6483382B2 (ja) * 2014-09-16 2019-03-13 株式会社Adeka 感光性樹脂組成物、その硬化物
JP6734416B2 (ja) * 2019-02-13 2020-08-05 株式会社Adeka 新規化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US758568A (en) * 1903-05-29 1904-04-26 William E Snediker Wrench.
GR79603B (hu) * 1982-07-24 1984-10-31 Pfizer
JPH0686379B2 (ja) * 1985-11-21 1994-11-02 アンヒュ−サ−‐ブッシュ・カンパニ−ズ、インコ−ポレイテッド グルコ−ス耐性因子およびその製造方法
US4985439A (en) * 1985-11-21 1991-01-15 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
US5192768A (en) 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
ES2164639T3 (es) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh Quinoxalinas, procedimiento para su preparacion y su empleo.

Also Published As

Publication number Publication date
HUT70040A (en) 1995-09-28
EP0579968A1 (de) 1994-01-26
NZ247993A (en) 1995-11-27
IL106147A (en) 1997-06-10
ZA934576B (en) 1994-01-31
KR940005577A (ko) 1994-03-21
CA2099213C (en) 2005-11-29
AU670435B2 (en) 1996-07-18
ATE184003T1 (de) 1999-09-15
GR3031853T3 (en) 2000-02-29
JP3605123B2 (ja) 2004-12-22
US5602146A (en) 1997-02-11
CA2099213A1 (en) 1993-12-28
CN1083477A (zh) 1994-03-09
ES2136628T3 (es) 1999-12-01
JPH0673012A (ja) 1994-03-15
EP0579968B1 (de) 1999-09-01
HU9301875D0 (en) 1993-09-28
DE59309756D1 (de) 1999-10-07
DK0579968T3 (da) 2000-03-27
AU4149293A (en) 1994-01-06
MX9303843A (es) 1994-01-31
IL106147A0 (en) 1993-10-20
TW304945B (hu) 1997-05-11

Similar Documents

Publication Publication Date Title
ZA937081B (en) Azaquinoxalines processes for their preparation and their use
HK1011971A1 (en) Quinoxalines, process for their preparation and their use
PH30118A (en) Phenylsulfonylamide pyrimidine
ES8500912A1 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
PH31682A (en) 4-Iminoquinolines, process for their preparation, and their use.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
GR74782B (hu)
GR850955B (hu)
IL95608A0 (en) 1-methoxypyrimidinyl-n-nitro-phenyl-1h,1,2,4-triazole-3-sulphonamide derivatives and herbicidal compositions containing the same
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
PH24990A (en) 1-(1 aryl-2-hydroxyethyl)-imidazoles and salts thereof
PL312966A1 (en) Derivatives of thiocarbamoil
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ZA874596B (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3-heteroaryl-(thio)ureas
MY115291A (en) New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides